Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Dimebon

No Benefit for Dimebon in Huntington’s

An antihistamine that failed to work in Alzheimer’s disease also fell short of expectations in Huntington’s disease, researchers reported.

In a randomized controlled trial, latrepirdine (Dimebon) didn’t improve cognition or global function compared with placebo, Ray Dorsey, MD, of Johns Hopkins, and colleagues reported online in the Archives of Neurology.

Currently, medications can mitigate… No Benefit for Dimebon in Huntington’s   



Parkinson’s Disease Dementia

high-cholesterol diet1 - visual hallucinations1 - preparing for appointment1 - abnormal tau protein1 - loss of neuronal connections1 - cholesterol-lowering drugs1 - dementia patients care1 - impaired balance and coordination1 - schizophrenia1 - cancer1 - beta secretase1 - ziveri1 - amentia2 - dopamine levels1 - blood sugar3 - mediterranean1 - structural imaging1 - physical exercise1 - movement disorders1 - dopamine-producing nerve cells1 - hypertension3 - emotional symptoms1 - inflammation1 - lou gehrig's disease1 - quality standards subcommittee1 - high-dose chemotherapy1 - dementia alliance1 - vci1 - development of parkinson's1 - frontotemporal dementia signs1 -